Correspondingly, ligand-independent signaling through the Shh pathway is a common feature in medulloblastoma, the most common pediatric brain tumor [5–7], and the Shh signaling pathway is a focal point of therapeutic development [8–10]. Here, SHH is linked to brain neoplasm.